Mk. Hristovakazmierski et al., A NEW APPROACH TO ENHANCE BIOAVAILABILITY OF BIOLOGICALLY-ACTIVE PEPTIDES - CONJUGATION OF A DELTA-OPIOID AGONIST TO BETA-CYCLODEXTRIN, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 831-834
The cyclic delta opioid agonist [p-I-Phe4]DPDPE, 1, was conjugated to
mono-6-amino-permethyl-beta-cyclodextrin at the C-terminus to improve
the bioavailability of 1. In the rat brain binding assay, the conjugat
e 8 showed an IC50 = 134 nM vs. a delta ligand and IC50 > 10 muM at th
e mu receptor, making it less potent and selective than 1. However, 8
shows antinociceptive properties (i.v.) in the mouse tail flick test a
nd prolonged activity.